← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Siloam Biosciences
Cincinnati, OH
$3,213,865
Total funding
6
Grants
Funding over time
peak $997.4K · FY2005–14$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$3,213,865 · 6
By mechanism
N44$1,994,691 · 2
R44$770,964 · 1
N43$348,570 · 2
R43$99,640 · 1
Investigators at Siloam Biosciences
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Largest grants
HHSN261201400049C; TOPIC 309 - DEVELOPMENT OF LOW COST, SMALL SAMPLE MULTI-ANALYTE TECHNOLOGIES FOR CANCER DIAGNOSIS, PROGNOSIS AND EARLY DETECTION; TITLE: LOW-VOLUME, ULTRA-SENSITIVE IMMUNODIAGNOSTIC$997,437
N44 · FY2014 · CA
TAS::75 0893::TAS RAPID QUANTITATIVE POINT OF CARE TEST FOR NICOTINE METABOLITE$997,254
N44 · FY2011 · DA
High-Throughput Plastic Microfabrication Technologies for Smart Lab-on-a-Chips$372,935
R44 · FY2008 · EB
High-Throughput Plastic Microfabrication Technologies for Smart Lab-on-a-Chips$303,315
R44 · FY2009 · EB
OTHER FUNCTIONS SILOAM"PHASE I, TOPIC 309, LOW VOLUME, ULTRA-SENSITIVE IMMUNODIA$198,570
N43 · FY2012 · CA
TAS::75 0893::TAS RAPID QUANTITATIVE POINT OF CARE TEST FOR NICOTINE METABOLITE$150,000
N43 · FY2010 · DA
Disposable Saliva biochip for Breast Cancer Biomarkers$99,640
R43 · FY2005 · CA
High-Throughput Plastic Microfabrication Technologies for Smart Lab-on-a-Chips$94,714
R44 · FY2007 · EB